In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis
Document type:
Zeitschriftenaufsatz
Author(s):
Schuster, Joachim ; Dreyhaupt, Jens ; Mönkemöller, Karla ; Dupuis, Luc ; Dieterlé, Stéphane ; Weishaupt, Jochen H. ; Kassubek, Jan ; Petri, Susanne ; Meyer, Thomas ; Grosskreutz, Julian ; Schrank, Berthold ; Boentert, Matthias ; Emmer, Alexander ; Hermann, Andreas ; Zeller, Daniel ; Prudlo, Johannes ; Winkler, Andrea S. ; Grehl, Torsten ; Heneka, Michael T. ; Johannesen, Siw ; Göricke, Bettina ; Witzel, Simon ; Dorst, Johannes ; Ludolph, Albert C.
Keywords:
ORIGINAL ARTICLE ; ALS and frontotemporal dementia ; amyotrophic lateral sclerosis ; randomized controlled trial ; rasagiline ; subgroup analysis